May and Baker

As a result, the Nigerian Exchange (NGX) Limited All-Share Index (ASI) rose 0.7 per cent to close at 39,170.95, just as market capitalisation rose N150.8 billion to close higher at N20.4 trillion.

NGX maintains bullish run with 0.1% gain

June 10, 2021

NSE opens week with 0.08 percent growth

January 11, 2021

NSE market capitalisation gains N239 billion on enhanced confidence

October 28, 2020

[email protected]: No social justice, religious, inter-ethnic tolerance – Mike Ozekhome

September 28, 2020

NSE resumes September trading with N46 billion growth

September 1, 2020

Transactions close flat on NSE

July 22, 2020

Mojisola Christianah Adeyeye, Director General, NAFDAC

Nigeria • Science

NAFDAC chief orders chloroquine manufacturing

March 30, 2020

NAFDAC explained that it only gave the approval to May and Baker, a Pharmaceutical Company, to produce more Chloroquine as a clinical trial for the cure of coronavirus.

NAFDAC explains reasons for approving chloroquine

March 21, 2020

NAFDAC Director General Christianah Mojisola Adeyeye

NAFDAC: Chloroquine for clinical trials only

March 21, 2020

Nigerian Stock Exchange NSE

NSE opens week with N181 billion loss

February 24, 2020

Nigerian Stock Exchange NSE

NSE indices record 0.21 percent loss

August 20, 2019